You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

16-042

Showing 1 - 25 of 5,842
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Metastatic Cancer, Advanced Cancer Trial in United States (Niraparib, TSR-042, Carboplatin-Paclitaxel)

Active, not recruiting
Has Results
  • Neoplasms
  • +6 more
  • Scottsdale, Arizona
  • +7 more
Oct 31, 2022

Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Primary Peritoneal Cancer Trial (Niraparib, Dostarlimab)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • +2 more
  • (no location specified)
Jul 26, 2022

Head Neck Cancer Trial in Cincinnati, Columbus (Niraparib, Dostarlimab)

Active, not recruiting
  • Head and Neck Cancer
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Jan 31, 2023

Gouty Arthritis Trial in Worldwide (Canakinumab)

Completed
Has Results
  • Gouty Arthritis
  • Seattle, Washington
  • +44 more
Jun 10, 2021

Heart Failure, Cardiorenal Disease, Renal Disfunction Trial in Rochester (ANX-042, Placebo)

Enrolling by invitation
  • Heart Failure
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 23, 2022

Tumors Trial in United States (Niraparib, Pembrolizumab, TSR-042 (Dostarlimab))

Completed
Has Results
  • Neoplasms
  • Whittier, Alaska
  • +15 more
Aug 29, 2022

COVID-19 Trial in United States (PUL-042 Inhalation Solution, Placebo)

Completed
  • COVID-19
  • PUL-042 Inhalation Solution
  • Placebo
  • Orange, California
  • +10 more
Jul 14, 2021

Endometrial Cancer Trial in Canada (Niraparib, TSR-042)

Active, not recruiting
  • Endometrial Cancer
  • Calgary, Alberta, Canada
  • +6 more
Nov 18, 2021

COPD Trial in London (Sterile Water Injection, PUL-042 Inhalation Solution)

Completed
  • COPD
  • Sterile Water Injection
  • PUL-042 Inhalation Solution
  • London, United Kingdom
    Imperial College Healthcare NHS Trust, St Mary Hospital
May 28, 2021

NSCLC Trial (pembrolizumab, carboplatin, paclitaxel)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • pembrolizumab
  • +3 more
  • (no location specified)
Aug 18, 2022

Endometrial Cancer, Cancer of the Endometrium Trial in Saint Louis (drug, radiation, procedure)

Recruiting
  • Endometrial Cancer
  • Cancer of the Endometrium
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 4, 2022

HPV-Related Carcinoma Trial (IBRX-042)

Not yet recruiting
  • HPV-Related Carcinoma
  • (no location specified)
Jul 26, 2023

Lymphoma, Relapsed/Refractory T-cell Lymphomas Trial in United States (Romidepsin, Bortezomib, duvelisib)

Active, not recruiting
  • Lymphoma
  • Relapsed/Refractory T-cell Lymphomas
  • Stanford, California
  • +10 more
Feb 2, 2023

COVID-19 Trial in United States (PUL-042 Inhalation Solution, Placebo)

Completed
  • COVID-19
  • PUL-042 Inhalation Solution
  • Placebo
  • Orange, California
  • +14 more
Sep 1, 2021

NSCLC Trial (pembrolizumab, carboplatin, paclitaxel)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • pembrolizumab
  • +3 more
  • (no location specified)
Aug 18, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Portland (Intratumoral Ipilimumab)

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Intratumoral Ipilimumab
  • Portland, Oregon
    Portland Providence Medical Center
Jan 8, 2023

Bipolar Disorder Trial in Toronto (Dialectical behavioral therapy)

Completed
  • Bipolar Disorder
  • Dialectical behavioral therapy
  • Toronto, Ontario, Canada
  • +1 more
Nov 17, 2022

Epilepsy Trial in Worldwide (Placebo, Brivaracetam, Antiepileptic drugs with market authorization available per country)

Completed
Has Results
  • Epilepsy
  • Placebo
  • +2 more
  • Phoenix, Arizona
  • +206 more
Jul 14, 2022

Melanoma Stage III, Melanoma Stage IV Trial in Washington, Boston, Pittsburgh (Dostarlimab (TSR-042) (singly), Dostarlimab

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • Dostarlimab (TSR-042) (singly)
  • Dostarlimab (TSR-042) and TSR-022 (combination)
  • Washington, District of Columbia
  • +2 more
Feb 22, 2022

Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

Recruiting
  • Breast Neoplasms
  • +10 more
  • Standard Therapy
  • +32 more
  • Birmingham, Alabama
  • +35 more
Nov 17, 2022

Tumors Trial in Worldwide (Dostarlimab)

Recruiting
  • Neoplasms
  • Dostarlimab
  • Birmingham, Alabama
  • +105 more
Nov 17, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +51 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 15, 2022

Ovarian Tumor Trial in United States (Dostarlimab, Bevacizumab, Niraparib)

Completed
  • Ovarian Neoplasm
  • Birmingham, Alabama
  • +9 more
Feb 20, 2023

Glaucoma, Open-Angle, Hypertension, Ocular Trial in Austin (NCX 470, Latanoprost 0.005%)

Completed
Has Results
  • Glaucoma, Open-Angle
  • Hypertension, Ocular
  • NCX 470
  • Latanoprost 0.005%
  • Austin, Texas
    Texan Eye
Nov 9, 2022

Chronic Low-back Pain, Older Adults, Core Stabilization Exercise Therapy Trial in Hong Kong (core stabilization exercise)

Recruiting
  • Chronic Low-back Pain
  • +2 more
  • core stabilization exercise
  • Hong Kong, Hong Kong
    The Hong Kong Polytechnic University
Sep 6, 2023